Stejskalova Zuzana, Rohan Zdenek, Rusina Robert, Tesar Adam, Kukal Jaromir, Kovacs Gabor G, Bartos Ales, Matej Radoslav
Department of Pathology and Molecular Medicine Third Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 14059, Prague 4 - Krc, Czech Republic.
Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
BMC Neurol. 2019 Mar 20;19(1):42. doi: 10.1186/s12883-019-1270-1.
We aimed to produce a detailed neuropathological analysis of pyramidal motor system pathology and provide its clinical pathological correlation in cases with definite progressive supranuclear palsy (PSP).
Pyramidal motor system pathologies were analyzed in 18 cases with neuropathologically confirmed PSP. Based on a retrospective clinical analysis, cases were subtyped according to Movement Disorder Society criteria for clinical diagnosis of PSP as probable, possible or suggestive of PSP with Richardson's syndrome (n = 10), PSP with predominant corticobasal syndrome (n = 3), PSP with predominant parkinsonism (n = 3), PSP with predominant speech/language disorder (n = 1), and PSP with progressive gait freezing (n = 1). Clinical manifestations of motor neuron involvement (pseudobulbar or bulbar signs and spasticity) were retrospectively assessed semiquantitatively. Neuropathologically, hyperphosphorylated tau-related pyramidal motor system neuronal, neuritic, and glial pathology using anti-tau AT8 clone immunohistochemistry, was also evaluated.
Clinical manifestations of pyramidal motor system involvement were found in patients with different PSP subtypes. A statistically significant higher load of tau pathology was found in the pyramidal system in PSP-Richardson's syndrome compared to other PSP subtypes (p = 0.016); however, there was no significant correlation between pyramidal system tau pathology and related motor clinical symptoms.
Tau pathology in the spinal cord and pyramidal motor system structures is very common in progressive supranuclear palsy and may neuropathologically supplement the distinction between classic Richardson's syndrome from other progressive supranuclear palsy subtypes.
我们旨在对锥体运动系统病变进行详细的神经病理学分析,并在确诊的进行性核上性麻痹(PSP)病例中提供其临床病理相关性。
对18例经神经病理学确诊为PSP的病例进行锥体运动系统病变分析。基于回顾性临床分析,根据运动障碍协会的PSP临床诊断标准,将病例分为可能、可能或提示为伴有理查森综合征的PSP(n = 10)、以皮质基底节综合征为主的PSP(n = 3)、以帕金森症为主的PSP(n = 3)、以言语/语言障碍为主的PSP(n = 1)和以进行性步态冻结为主的PSP(n = 1)。对运动神经元受累的临床表现(假性球麻痹或球麻痹体征及痉挛)进行回顾性半定量评估。在神经病理学上,还使用抗tau AT8克隆免疫组织化学评估了与高磷酸化tau相关的锥体运动系统神经元、神经突和胶质细胞病变。
在不同PSP亚型的患者中发现了锥体运动系统受累的临床表现。与其他PSP亚型相比,PSP-理查森综合征的锥体系统中tau病变负荷在统计学上显著更高(p = 0.016);然而,锥体系统tau病变与相关运动临床症状之间无显著相关性。
脊髓和锥体运动系统结构中的tau病变在进行性核上性麻痹中非常常见,并且在神经病理学上可能有助于区分经典的理查森综合征与其他进行性核上性麻痹亚型。